What You Should Know: - Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance. The price cut goes into effect January 1, 2024. - The price cut milestone comes in addition to decisions taken in June 2022 to lower diabetes medicines costs: the launch of an unbranded Lantus biologic at -60% versus Lantus list price, and a cap on out-of-pocket costs on insulin to $35 for all people
Read More
insulin
Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B
What You Should Know: - Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity value of approximately $2.9B. - The acquisition is a strategic fit for Sanofi at the intersection of the company’s growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet
Read More
Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month
What You Should Know: - Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month at participating retail pharmacies. - The historic price cut makes it easier to access Lily insulin for Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable
Read More
Dexcom Ventures Invests in MedCrypt’s Medical Device Cybersecurity Platform
What You Should Know: - MedCrypt, the proactive cybersecurity solution provider for medical devices and manufacturers, will announce the close of a Series B extension round led by Dexcom Ventures, bringing the company's total to date to $36.4M. - With support from three major investors, Johnson & Johnson Innovations, Intuitive Ventures, and Dexcom Ventures, MedCrypt continues to lead the way in developing cybersecurity technologies and infrastructure for life-saving medical
Read More
22 Executive Digital Health Predictions to Watch in 2023
Jon Bloom, MD, CEO and Co-founder of Podimetrics From a digital health perspective, 2022 was a reset year for many and a serious reality check. We went from sky high growth to the sky is falling, and in 2023 I think this market correction movement will continue forward. To me, the biggest surprise of 2022 was that despite the market tanking, digital health companies continued to truck forward with huge deals. This includes massive acquisitions like Amazon and OneMedical, as well as deals like
Read More
Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing
What You Should Know: - Prescryptive Health, a healthcare technology company on a mission to rewrite the script for the U.S. pharmaceutical market partners with Eli Lilly and Company on a new and first-to-market subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits. - Through a flat, per-member, per-month subscription fee, employers can offer insulin to their employees with predictable, affordable, and transparent costs.
Read More
PatientsLikeMe Partners with LetsGetChecked to Offer Members Access to Home Testing Solutions
What You Should Know: - PatientsLikeMe (PLM), the trusted community health network that empowers patients to take charge of their health, announced its partnership with LetsGetChecked, a global healthcare solutions company. - The partnership will provide PLM’s 1 million members with access to enhanced patient support capabilities for testing. PLM’s expansive patient community can now utilize LetsGetChecked’s suite of offerings directly through the PLM platform and receive a discount on
Read More
Dexcom Receives FDA Clearance for G7 Continuous Glucose Monitoring (CGM) System
What You Should Know: - The FDA has cleared Dexcom G7 continuous glucose monitoring (CGM) system in the U.S. for people with all types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution. - Cleared as an integrated continuous glucose monitoring (iCGM) system, Dexcom G7 will be part of the most connected CGM ecosystem in the world, with real-time connectivity that can drive integrated insulin delivery systems, connect
Read More
How Continuous Glucose Monitoring Can Alleviate Language Barriers in Diabetes Care
As an endocrinologist with 19 years of experience in treating patients with diabetes, one of the most important lessons I’ve learned is that communication is key. Patients with diabetes live with the heavy burden of making choices and taking action every single day to manage their blood glucose levels. Thankfully, advancements in technology have come incredibly far, giving way to tools like continuous glucose monitors (CGM), automated insulin delivery systems and more. But for
Read More
Virta Health Helps AutoZone Employees Reverse Type 2 Diabetes
What You Should Know: - Type 2 diabetes reversal leader Virta Health revealed promising one-year outcomes from its partnership with AutoZone, Inc., a retailer and distributor of automotive replacement parts and accessories in the Americas. - Virta provides virtual, continuous health coaching, medical supervision and personalized nutrition to help patients reverse their metabolic disease, lose weight, + get off medications. At one year, AutoZoners experience long-term blood sugar control
Read More
